BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23364206)

  • 1. Advanced native kidney renal cell carcinoma in renal transplant recipients: role of sirolimus as dual anti-cancer and anti-rejection agent.
    Javaid MM; Chowdhury S; Henderson A; Olsburgh J
    Clin Nephrol; 2013 Feb; 79(2):154-60. PubMed ID: 23364206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.
    Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM
    Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Cell Cancer in a European Regional Renal Transplant Population: Is There a Role for Immediate Native Renal Radiological Surveillance Before and After Transplantation?
    Moon A; Rogers A; Talbot D; Rix D
    Transplant Proc; 2015; 47(6):1840-4. PubMed ID: 26293060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial nephrectomy for renal cell carcinoma in long-term renal allografts: operative and post-operative considerations.
    Cox A; Nguan CY; Luke PP
    Can J Urol; 2005 Dec; 12(6):2887-90. PubMed ID: 16401374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with sirolimus for an angiomyolipoma mimicking renal cell carcinoma in a transplanted kidney.
    Chiu HF; Wen MC; Li JR; Ho HC; Shu KH
    Transpl Int; 2015 Sep; 28(9):1116-20. PubMed ID: 25790294
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Moris D; Kakavia K; Argyrou C; Garmpis N; Bokos J; Vernadakis S; Diles K; Sotirchos G; Boletis J; Zavos G
    Anticancer Res; 2017 Feb; 37(2):773-779. PubMed ID: 28179329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular ultrasound examination of transplanted kidneys allows early diagnosis of renal cell carcinoma and conservative nephron sparing surgery.
    Lentini P; Granata A; Ciancio A; Gallieni M
    Arch Ital Urol Androl; 2011 Dec; 83(4):195-9. PubMed ID: 22670317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native nephrectomy for renal cell carcinoma in transplant recipients.
    Suson KD; Sausville JE; Sener A; Phelan MW
    Transplantation; 2011 Jun; 91(12):1376-9. PubMed ID: 21512434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma in kidney allografts: a case series from a single center.
    Barama A; St-Louis G; Nicolet V; Hadjeres R; Daloze P
    Am J Transplant; 2005 Dec; 5(12):3015-8. PubMed ID: 16303018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell Carcinoma.
    Machhi R; Mandelbrot DA; Al-Qaoud T; Astor BC; Parajuli S
    Am J Nephrol; 2020; 51(10):777-785. PubMed ID: 32998152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Squamous Cell Carcinoma of a Native Kidney After Renal Transplant: A Case Report.
    Jakes A; Jani P; Menon M; Adams K; Edey M; Fleming S; Bhandari S
    Transplant Proc; 2016; 48(1):259-61. PubMed ID: 26915879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous laparoendoscopic single-site radical nephrectomy for native kidney and open nonischemic partial nephrectomy to treat concomitant renal cell carcinomas in native and transplant kidneys and to preserve allograft function.
    Sankari BR; Chueh SC
    Urology; 2012 Jan; 79(1):139-44. PubMed ID: 22055688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus: a new mammalian target of rapamycin inhibitor for the treatment of advanced renal cell carcinoma.
    Grgic T; Mis L; Hammond JM
    Ann Pharmacother; 2011 Jan; 45(1):78-83. PubMed ID: 21177421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.
    Cheung CY; Lam MF; Lee KC; Chan GS; Chan KW; Chau KF; Li CS; Chan TM; Lai KN
    Int Urol Nephrol; 2011 Sep; 43(3):675-80. PubMed ID: 21547472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.
    Su MZ; Campbell NA; Lau HM
    Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Papillary Carcinoma Developed in a Kidney Transplant Recipient With Late IgA-Nephropathy.
    Melandro F; Guglielmo N; Nudo F; Pretagostini R; Mennini G; Poli L; Giannakakis K; Berloco PB
    Exp Clin Transplant; 2016 Aug; 14(4):445-6. PubMed ID: 25184211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis and treatment of renal cell carcinoma of native kidney in kidney transplantation.
    García Álvarez T; Mazuecos Blanca A; Navas García N; Calle García L; Vallejos Roca E; Moreno Salazar A; Soto Villalba J; Collantes Mateos R; Rivero Sánchez M
    Nefrologia; 2011; 31(5):567-72. PubMed ID: 21959723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Tumor in Allogeneic Kidney Transplant Recipient.
    Bieniasz M; Chmura A; Kwapisz M; Czerwińska M; Kieszek R; Domagała P; Wszoła M; Serwańska-Świętek M; Górnicka B; Durlik M; Pączek L; Kwiatkowski A
    Transplant Proc; 2016 Jun; 48(5):1849-54. PubMed ID: 27496506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian Target of Rapamycin Inhibitor Monotherapy: Efficacy in Renal Transplantation.
    Franco A; Más-Serrano P; Perez Contreras J; Jiménez L; Rodriguez D; Olivares J
    Transplant Proc; 2015 Oct; 47(8):2364-7. PubMed ID: 26518928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.